Phloroglucinol Market

Phloroglucinol Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Phloroglucinol market is projected to grow at a CAGR of 3.5% from 2025 to 2035, driven by its increasing use in gastrointestinal disorders, expanding pharmaceutical applications, and its role in the management of spastic conditions. Phloroglucinol is an aromatic compound that exerts antispasmodic effects by inhibiting smooth muscle contraction through its action on phosphodiesterase enzymes, thereby providing relief from abdominal cramping and spasms.

Phloroglucinol is primarily used in the treatment of irritable bowel syndrome (IBS), intestinal spasms, and colicky pain, as well as in gastrointestinal procedures to relieve discomfort caused by smooth muscle spasms. Additionally, it is employed in the management of urinary tract spasms and dysmenorrhea (painful menstruation). Due to its relatively safe profile and efficacy in treating spasmodic conditions, it is increasingly used in combination with other gastrointestinal therapies.

Europe is the leading market for Phloroglucinol, with high demand driven by its well-established use in prescription medications and over-the-counter formulations for gastrointestinal relief. Asia-Pacific is expected to see significant growth, fueled by rising awareness of gastrointestinal diseases, an aging population, and improving access to healthcare. North America also shows steady demand, particularly for pharmaceutical-grade formulations. Latin America and Africa exhibit moderate growth, with Phloroglucinol being used in both traditional and modern healthcare settings.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Phloroglucinol
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Key End-Use Industries
- Pharmaceutical Industry
- Hospitals & Clinics
- Research Institutions

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

June 2, 2025

What is Phloroglucinol?

Phloroglucinol is an organic compound primarily used as a spasmolytic agent to treat conditions associated with smooth muscle spasms.

What is the market growth of Phloroglucinol?

The global phloroglucinol market is expected to grow at a CAGR of 3.5% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of gastrointestinal disorders, particularly those involving spasms, such as irritable bowel syndrome.

What are the drivers of the Phloroglucinol market?

Key drivers of the phloroglucinol market include the increasing global prevalence of digestive disorders like IBS and other conditions involving gastrointestinal spasms. The growing demand for non-narcotic and non-habit-forming treatments that effectively relieve abdominal discomfort and pain is another significant factor.

Who are the key players operating in the Phloroglucinol market?

Key players in the phloroglucinol market include pharmaceutical companies such as Mylan, Boehringer Ingelheim, and Sandoz, which manufacture and distribute generic versions of phloroglucinol-based medications.

Which region will exhibit the fastest growth in the Phloroglucinol market?

The Asia-Pacific region is expected to exhibit the fastest growth in the phloroglucinol market. This is due to the increasing incidence of gastrointestinal disorders in countries like China, India, and Southeast Asia, where digestive health is a major concern.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com